Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Contraception ; 65(5): 379-84, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12057793

RESUMO

The present study was undertaken to evaluate the dose-dependent effects of a leaf extract of Stephania hernandifolia on testicular activities in albino rats. Whether this leaf extract has any toxic effect on metabolic organs or on the liver or kidney was studied. Adult male Wistar rats, maintained under standard laboratory conditions, were forcefully fed with the aqueous extract of these leaves at the dose of 2 g or 4 g of leaves/mL distilled water/100 g body weight/day for 28 days. All the animals, along with vehicle-treated controls, were killed on the Day 29 of the experiment. Treatment with this leaf extract at both doses resulted in significant reduction in relative weight in the testis, the seminal vesicles, the prostate, and the epididymis without any significant change in the liver and kidney weight in comparison to control. Activities of testicular steroidogenic key enzymes and plasma testosterone level were decreased significantly, along with a significant reduction in the number of germ cells at stage VII of the spermatogenic cycle and in the seminiferous tubular diameter in both treated groups in comparison to control. Activities of glutamate oxaloacetate transaminase, glutamate pyruvate transaminase, acid phosphatase, and alkaline phosphatase were not altered significantly in the liver and kidney in both treated groups compared with controls. We concluded that treatment with an aqueous extract of leaves resulted in diminution in the activities of testicular androgenic key enzymes and plasma level of testosterone along with inhibition of spermatogenesis without any induction of hepatic and renal toxicity.


Assuntos
Anticoncepcionais Masculinos/farmacologia , Bloqueadores de Espermatogênese/farmacologia , Stephania/química , Testículo/efeitos dos fármacos , 17-Hidroxiesteroide Desidrogenases/análise , 3-Hidroxiesteroide Desidrogenases/análise , Animais , Relação Dose-Resposta a Droga , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Masculino , Extratos Vegetais/farmacologia , Folhas de Planta/química , Ratos , Ratos Wistar , Testículo/fisiologia , Testosterona/sangue
2.
Reprod Toxicol ; 15(2): 221-5, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11297880

RESUMO

Quantitative evaluation of ovarian Delta5,3beta- hydroxysteroid dehydrogenese (HSD) and 17beta - HSD activities along with radioimmunoassay of plasma levels of gonadotrophins (FSH and LH), and estradiol (E2), and quantification of different types of developing follicles and regressive follicles were noted in mature rats of the Wistar strain following treatment with cyclophosphamide at a dose of 5 mg/kg body weight/day for 28 days. A significant reduction in plasma levels of LH and E2 along with significant diminution in the activities of ovarian Delta5,3beta -HSD and 17beta- HSD were observed following cyclophosphamide treatment for 28 days without any change in the plasma level of FSH. This treatment also produced a marked degree of degeneration in different types of follicles. Coadministration of hCG at 5 IU/kg body weight/day for 28 days in the cyclophosphamide-treated group provided significant protection except with respect to plasma LH. These results suggest the possibility of an indirect action of cyclophosphamide at the level of the ovary.


Assuntos
Antineoplásicos Alquilantes/farmacologia , Gonadotropina Coriônica/farmacologia , Ciclofosfamida/farmacologia , Imunossupressores/farmacologia , Folículo Ovariano/efeitos dos fármacos , Ovário/efeitos dos fármacos , 17-Hidroxiesteroide Desidrogenases/metabolismo , 3-Hidroxiesteroide Desidrogenases/metabolismo , Administração Oral , Animais , Antineoplásicos Alquilantes/administração & dosagem , Gonadotropina Coriônica/administração & dosagem , Ciclofosfamida/administração & dosagem , Combinação de Medicamentos , Estradiol/sangue , Estro/efeitos dos fármacos , Feminino , Hormônio Foliculoestimulante/sangue , Imunossupressores/administração & dosagem , Injeções Subcutâneas , Hormônio Luteinizante/sangue , Tamanho do Órgão/efeitos dos fármacos , Folículo Ovariano/enzimologia , Folículo Ovariano/patologia , Ovário/enzimologia , Ovário/patologia , Ratos , Ratos Wistar
3.
Folia Biol (Krakow) ; 47(3-4): 73-6, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10754790

RESUMO

Steroidogenic key enzymes, i.e. delta 5-3 beta and 17 beta-hydroxysteroid dehydrogenase (delta 5-3 beta and 17 beta-HSD) activities, in the testis and Bidder's organ of the toad were inhibited and ascorbic acid synthesis in these organs was decreased by a wide range of lithium concentration in in vitro study. A significant inhibition was noted at a concentration of 2.0 mM, which is easily achieved in the blood during the treatment of manic patients by lithium chloride. This experiment reflected that lithium exerts a direct inhibitory effect on hydroxysteroid dehydrogenase activities in the testis and Bidder's organ--a rudimentary ovary in Bufo.


Assuntos
17-Hidroxiesteroide Desidrogenases/metabolismo , 3-Hidroxiesteroide Desidrogenases/metabolismo , Antimaníacos/farmacologia , Cloreto de Lítio/farmacologia , Testículo/efeitos dos fármacos , 17-Hidroxiesteroide Desidrogenases/efeitos dos fármacos , 3-Hidroxiesteroide Desidrogenases/efeitos dos fármacos , Animais , Ácido Ascórbico/metabolismo , Bufonidae/fisiologia , Masculino , Testículo/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...